PEG–PLA-Coated and Uncoated Radio-Luminescent CaWO4 Micro- and Nanoparticles for Concomitant Radiation and UV-A/Radio-Enhancement Cancer Treatments

Authors:

Abstract
Currently, there is great interest in the development of ways to achieve the benefits of radiation treatment with reduced negative effects. The present study demonstrates the utilization of Radio-Luminescent Particles (RLPs) as a means to achieve radio-sensitization/enhancement and their ability to affect head and neck cancer cell cultures (in vitro) and xenografts (in vivo). Our approach utilizes a naturally-abundant radio-luminescent mineral, calcium tungstate (CaWO4) in its micro or nanoparticulate form for generating secondary UV-A light by γ ray/X-ray photons. In vitro tests demonstrate that an un-optimized RLP materials (uncoated CaWO4 (CWO) microparticles (MPs) and PEG-PLA-coated CWO nanoparticles (NPs)) induce a significant enhancement of the tumor suppressive effect of X-rays/γ rays in both radio-sensitive and radio-resistant cancer models; uncoated CWO MPs and PEG-PLA-coated CWO NPs demonstrate comparable radio-sensitization efficacy in vitro. Mechanistic studies reveal that concomitant CaWO4 causes increased mitotic death in radio-resistant cells treated with radiation, whereas CaWO4 sensitizes radio-sensitive cells to X-ray-induced apoptosis/necrosis. Radio-sensitization efficacy of intratumorally injected CaWO4 particles (uncoated CWO MPs and PEG-PLA-coated CWO NPs) is also evaluated in vivo in mouse head and neck cancer xenografts. Uncoated CWO MPs suppress tumor growth more effectively than PEG-PLA-coated CWO NPs. Based on theoretical considerations, an argument is proposed that uncoated CWO MPs release sub-toxic levels of tungstate ions, which cause increased effects of photoelectric electron emissions. The effect of folic acid functionalization on in vitro radio-sensitization behavior produced by PEG-PLA-coated CWO NPs is studied. Surface folic acid results in a significant improvement in radio-sensitization efficiency of CaWO4.
Funding Information
  • National Cancer Institute (P30 CA023168)
  • Indiana Clinical and Translational Sciences Institute
  • National Research Foundation of Korea (2012k1A1A2A01056095)
  • Korea Institute of Science and Technology
  • Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET-1264336)
  • School of Chemical Engineering, Purdue University
  • Purdue Office of the Executive Vice President for Research and Partnerships, Purdue University

This publication has 43 references indexed in Scilit: